|
National Stock Number(NSN): 6505-01-048-2953 (6505010482953, 010482953)
| NIIN: |
01-048-2953 |
Item Name: |
QUINIDINE SULFATE TABLETS |
INC: |
09583
|
| FSC: |
6505
|
Assignment Date: |
Sep-22-1977 |
CRIT: |
X |
IIG: |
09583 |
| ISC: |
5 |
Date Standardized: |
Sep-22-1977 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00005-3558-42 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
3 |
9 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
200.000 MILLIGRAMS QUINIDINE SULFATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
90.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| FEAT |
SPECIAL FEATURES |
WITH 3-PART LABEL AND CHILD RESISTANT CLOSURE |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| THPE |
THERAPEUTIC EQUIVALENT |
ANY A RATED DRUG |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|